These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12643110)

  • 1. Management of the insulin resistance syndrome.
    Desouza C; Gilling L; Fonseca V
    Curr Diab Rep; 2001 Oct; 1(2):140-7. PubMed ID: 12643110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome.
    Yamakita T; Ishii T; Mori T; Yoshioka K; Sato T; Tanaka S; Kurimasa H; Fujita K; Fujii S
    Diabetes Res Clin Pract; 1998 Dec; 42(3):205-8. PubMed ID: 9925352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiologists and the management of blood sugar: a Chinese perspective.
    Hu DY; Guo YF
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):509. PubMed ID: 18719711
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical implications of the insulin resistance syndrome.
    Garvey WT; Hermayer KL
    Clin Cornerstone; 1998; 1(3):13-28. PubMed ID: 10682170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of nateglinide in impaired glucose tolerance subjects].
    Hirose T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():438-43. PubMed ID: 15779419
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin sensitizers and atherosclerosis.
    Yatoh S; Yamada N
    J Atheroscler Thromb; 2002; 9(6):276-9. PubMed ID: 12560587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients.
    Florescu D; Kotler DP
    Antivir Ther; 2007; 12(2):149-62. PubMed ID: 17503657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.
    Gupta A; Gupta R; Sarna M; Rastogi S; Gupta VP; Kothari K
    Diabetes Res Clin Pract; 2003 Jul; 61(1):69-76. PubMed ID: 12849925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetes in patients with severe obesity.
    Scheen AJ
    Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes.
    Kobayashi K; Amemiya S; Higashida K; Ishihara T; Sawanobori E; Kobayashi K; Mochizuki M; Kikuchi N; Tokuyama K; Nakazawa S
    Metabolism; 2000 Feb; 49(2):186-91. PubMed ID: 10690942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance syndrome: options for treatment.
    Granberry MC; Fonseca VA
    South Med J; 1999 Jan; 92(1):2-15. PubMed ID: 9932820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of troglitazone in treating the insulin resistance syndrome.
    Granberry MC; Schneider EF; Fonseca VA
    Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of diabetes and obesity in the United States.
    Muhammad S
    Compend Contin Educ Dent; 2004 Mar; 25(3):195-8, 200, 202; quiz 204. PubMed ID: 15641325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes.
    Ortiz-Flores AE; Luque-Ramírez M; Escobar-Morreale HF
    Expert Opin Pharmacother; 2018 Dec; 19(17):1915-1926. PubMed ID: 30289728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of troglitazone on insulin sensitivity.
    Henry RR
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management strategies for coexisting diabetes mellitus and obesity.
    Scheen AJ
    Drugs; 2003; 63(12):1165-84. PubMed ID: 12790691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The metabolic syndrome].
    Internist (Berl); 1995 May; 36(5 Suppl Metabolisc):1-12. PubMed ID: 9403089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.